IDiyas

For the Inventor, By the Inventor

Pan-Chyr Yang

Taipei, Taiwan

Pan-Chyr Yang

Webpage
USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 53(Granted Patents)


Company Filing History:

goldMedal21 out of 1,712 
 
National Taiwan University
 patents
silverMedal15 out of 685 
 
Academia Sinica
 patents
bronzeMedal3 out of 6 
 
Advpharma, Inc.
 patents
4. 2 out of 181 
 
National Health Research Institutes
 patents
5. 1 out of 18 
 
Taichung Veterans General Hospital
 patents
6. 1 out of 119 
 
National Chung Hsing University
 patents
7. 1 out of 1,269 
 
University of North Carolina at Chapel Hill
 patents
8. 1 out of 1,195 
 
National Yang Ming Chiao Tung University
 patents
9. 1 out of 133 
 
Taipei Medical University
 patents
10. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2024

where 'Filed Patents' based on already Granted Patents

31 patents (USPTO):
1. 12109207 - Methods of using 4(1)-quinolone derivatives (2024-10-08),
2. 12085570 - Biomarkers for lung cancer stem cells (2024-09-10),
3. 12013513 - Metasurface based device for generating abrupt autofocusing beam (2024-06-18),
4. 11919886 - 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases (2024-03-05),
5. 11891447 - Method for treating cancer using CD14 antagonists (2024-02-06),
6. 11834682 - Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness (2023-12-05),
7. 11638705 - 4(1H)-quinolone derivatives and uses thereof (2023-05-02),
8. 11447778 - TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases (2022-09-20),
9. 11434229 - 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases (2022-09-06),
10. 11214774 - PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment (2022-01-04),
11. 10888568 - Pharmaceutical composition for treatment of cancer using phenothiazine (2021-01-12),
12. 10865388 - Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness (2020-12-15),
13. 10765681 - Purine compounds possessing anticancer activity (2020-09-08),
14. 10584341 - Antagonistic PDL1 aptamers and their applications in cancer therapy (2020-03-10),
15. 10533179 - Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity (2020-01-14),

Title: The Innovative Journey of Pan-Chyr Yang

Introduction: Pan-Chyr Yang, a distinguished inventor hailing from Taipei, Taiwan, has made significant contributions to the field of innovation with his groundbreaking work in various patents.

Latest Patents: Pan-Chyr Yang's recent patents focus on cutting-edge technologies in the healthcare sector, particularly in the development of advanced medical devices for early disease detection and treatment.

Career Highlights: With a career spanning over two decades, Pan-Chyr Yang has established himself as a leading figure in the innovation landscape. His pioneering research has led to the creation of several revolutionary products that have transformed the industry.

Collaborations: Throughout his career, Pan-Chyr Yang has collaborated with top research institutions, universities, and companies worldwide to further his inventions. His partnerships have been instrumental in bringing his visionary ideas to life.

Conclusion: Pan-Chyr Yang's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his position as a trailblazer in the world of inventors. His work continues to inspire future generations of innovators to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…